Zevra Therapeutics (ZVRA) Gross Profit (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Gross Profit of $38.18 million for Q2 2026, up 182.3% from $13.52 million a year earlier and up 11.2% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Gross Profit (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Zevra Therapeutics was $130 million, up 191.3% year-over-year; for FY2025, it was $90.02 million, up 455.8% from FY2024.
- Annual Gross Profit shows a four-year compound annual growth rate of 35.6% (FY2021 to FY2025).
- In prior years, Zevra Therapeutics' Gross Profit was $16.2 million in FY2024 (-36.0%), $25.29 million in FY2023 (+154.4%), $9.94 million in FY2022 (-62.6%) and $26.59 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Gross Profit in data going back to Q3 2019.
- On a year-over-year basis, Gross Profit has increased in each of the last three quarters, with growth averaging 149.5% over the last six quarters.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q2 2023, with growth of 523.9%; the weakest was Q2 2024, with a decline of 88.8%.
- According to Business Quant data, Gross Profit for the three prior quarters was $34.32 million (Q1 2026), $32.64 million (Q4 2025) and $24.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.18 Mn |
| Mar 31, 2026 | 34.32 Mn |
| Dec 31, 2025 | 32.64 Mn |
| Sep 30, 2025 | 24.86 Mn |
| Jun 30, 2025 | 13.52 Mn |
| Mar 31, 2025 | 19.06 Mn |
| Dec 31, 2024 | 10.65 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 876,000.00 |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 11.69 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 7.79 Mn |
| Mar 31, 2023 | 3.05 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.73 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 3.96 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 1.97 Mn |
API Access
Zevra Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();